The Patent Finder

Orapharma, Inc.

Also on record
Records under this name other than the patents Orapharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Showing 1 to 6 of 6 · Back to Orapharma, Inc.

PatentTitleStatus Expires Confidence
US 7,799,824Quaternary Salt CCR2 Antagonists
Formerly held
In force
 · High confidence
In forceHigh confidence
US 6,682,348Dispensing Apparatus and Cartridge
Term ended
Term ended Mar 29, 2022 · High confidence
Term endedTerm ended Mar 29, 2022High confidence
US 7,699,609Dispensing Apparatus and Cartridge with Deformable Tip
Term ended
Term ended Mar 29, 2022 · High confidence
Term endedTerm ended Mar 29, 2022High confidence
US 6,946,118Formulations for treating or preventing mucositis
Formerly held
Lapsed on the fee record
Ended Sep 20, 2013 · From the USPTO record
Lapsed on the fee recordEnded Sep 20, 2013From the USPTO record
US 6,893,665Formulations for Treating or Preventing Mucositis
Formerly held
Lapsed on the fee record
Ended May 17, 2013 · Medium confidence
Lapsed on the fee recordEnded May 17, 2013Medium confidence
US 6,683,067Formulations for Treating or Preventing Mucositis
Formerly held
Lapsed on the fee record
Ended Jan 27, 2012 · Medium confidence
Lapsed on the fee recordEnded Jan 27, 2012Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited